Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › Jeffersonville › NPI 1215527668
Lab

Ssa Ventures, LLC

Ssa Ventures, LLC was paid $301K by Medicaid between Aug 2021 and Oct 2023, across 11 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 54% of everything it billed.

33Billing provider infoSSA VENTURES, LLC
JEFFERSONVILLE, IN 47130
33aNPI1215527668assigned 01/20/2021
28Total paid$301K
24GClaims22,213
24DCodes billed11
24AFirst – last monthAug 2021 – Oct 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Indiana

Rank by total paid#20 of 66
Median peer was paid$53K
This provider vs. median5.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20217,948$78K
202213,701$213K
2023564$10K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 54% 6,292 2,832 $164K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 28% 9,476 3,802 $85K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 17% 6,194 2,805 $51K
0134A <1% 33 16 $295.20
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 61 61 $205.24
86328 <1% 35 13 $45.28
0124A <1% 21 19 $36.90
G0008 Administration of influenza virus vaccine 0% 24 24 $0.00
90686 0% 23 23 $0.00
91313 0% 33 16 $0.00
91312 0% 21 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHONAKER, SHAWN (OWNER)